Boost For Prostate Cancer Screening – Report Shows Mortality Reduction As High As 31%

The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality has been given a boost with new data from the European Randomized Study of Screening for Prostate Cancer (ERSPC). This shows the true impact to be far higher than previously reported – up to 31%.

This entry was posted on Monday, December 21st, 2009 at 12:00 am and is filed under Cancer News. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.